Clarity
State what was assessed, what evidence was used, and where the limits are.
About Ayliea
Ayliea helps healthcare vendors and organizations explain their AI environment through independent, evidence-backed assessment work.
Named assessorDaviyon Daniels, CISSP
Daviyon Daniels is Ayliea's named assessor. He evaluates the scoped AI environment, reviews the available evidence, documents findings and limitations, and signs the final assessment.
The named-assessor model makes accountability visible. Customers know who performed the work; reviewers can see who formed the conclusions.
What independent means here
Ayliea is engaged as an external, paid assessor rather than as the organization being assessed, its regulator, or the receiving healthcare reviewer. Independence does not imply governmental authority, statutory auditor status, or a guarantee that another organization will accept the report.
Potential conflicts and prior advisory work should be identified during scoping. The assessor may correct factual errors while retaining a supported professional conclusion even when a different commercial outcome is preferred.
Operating principles
State what was assessed, what evidence was used, and where the limits are.
Evaluate in-scope evidence without promising a commercial or compliance outcome.
Connect material findings to the evidence and reasoning behind them.
Put a named professional behind the signed conclusion.
Next step
Use a 20-minute scoping call to clarify what the reviewer is asking for, what belongs in scope, and whether an independent Ayliea assessment is a fit.